The heterozygosity of Corfu δ0β+ is detected in 1–2% of the β-thalassemia carrier population and presents a distinct hematological phenotype of microcytic, hypochromic anemia with normal HbA2 and elevated HbF levels. This evidence concerns the gene HBA2 and anemia.